Smith & Nephew plc (NYSE:SNN) Stock Position Lifted by Ridgewood Investments LLC

Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew plc (NYSE:SNN) by 6.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 75,979 shares of the medical equipment provider’s stock after purchasing an additional 4,336 shares during the period. Smith & Nephew comprises approximately 0.9% of Ridgewood Investments LLC’s holdings, making the stock its 18th largest position. Ridgewood Investments LLC’s holdings in Smith & Nephew were worth $1,868,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. First Trust Direct Indexing L.P. grew its position in Smith & Nephew by 6.9% in the third quarter. First Trust Direct Indexing L.P. now owns 9,659 shares of the medical equipment provider’s stock worth $301,000 after acquiring an additional 626 shares in the last quarter. Inspire Advisors LLC lifted its stake in shares of Smith & Nephew by 3.0% in the second quarter. Inspire Advisors LLC now owns 22,286 shares of the medical equipment provider’s stock worth $552,000 after buying an additional 639 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Smith & Nephew by 31.8% in the fourth quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after buying an additional 718 shares during the last quarter. Townsquare Capital LLC lifted its stake in shares of Smith & Nephew by 5.4% in the third quarter. Townsquare Capital LLC now owns 14,759 shares of the medical equipment provider’s stock worth $460,000 after buying an additional 761 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Smith & Nephew by 8.6% during the 2nd quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock valued at $257,000 after purchasing an additional 819 shares during the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

SNN has been the subject of several research analyst reports. StockNews.com cut shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Finally, Berenberg Bank cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th.

Smith & Nephew Stock Performance

Smith & Nephew stock traded down $0.29 on Friday, hitting $24.03. The company’s stock had a trading volume of 272,837 shares, compared to its average volume of 1,144,325. The firm has a market cap of $10.51 billion, a P/E ratio of 12.26, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The company has a fifty day moving average price of $25.02 and a 200-day moving average price of $27.76. Smith & Nephew plc has a one year low of $23.65 and a one year high of $31.72.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.